188 related articles for article (PubMed ID: 31903143)
1. A supramolecular protein chaperone for vaccine delivery.
Wang Z; Shang Y; Tan Z; Li X; Li G; Ren C; Wang F; Yang Z; Liu J
Theranostics; 2020; 10(2):657-670. PubMed ID: 31903143
[No Abstract] [Full Text] [Related]
2. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
[TBL] [Abstract][Full Text] [Related]
3. A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy.
Xu Y; Wang Y; Yang Q; Liu Z; Xiao Z; Le Z; Yang Z; Yang C
Theranostics; 2019; 9(11):3388-3397. PubMed ID: 31244959
[TBL] [Abstract][Full Text] [Related]
4. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses.
Kumar S; Kesharwani SS; Kuppast B; Bakkari MA; Tummala H
J Control Release; 2017 Sep; 261():263-274. PubMed ID: 28669593
[TBL] [Abstract][Full Text] [Related]
6. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
[TBL] [Abstract][Full Text] [Related]
7. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
8. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
9. Simple nanoliposomes encapsulating
Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
[TBL] [Abstract][Full Text] [Related]
10. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.
Han JA; Kang YJ; Shin C; Ra JS; Shin HH; Hong SY; Do Y; Kang S
Nanomedicine; 2014 Apr; 10(3):561-9. PubMed ID: 24262997
[TBL] [Abstract][Full Text] [Related]
11. Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy.
Luo L; Liu C; He T; Zeng L; Xing J; Xia Y; Pan Y; Gong C; Wu A
Nanoscale; 2018 Nov; 10(46):22035-22043. PubMed ID: 30452049
[TBL] [Abstract][Full Text] [Related]
12. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines using supramolecular hydrogels of NSAID-modified peptides as adjuvants abolish tumorigenesis.
Wang Z; Liang C; Shi F; He T; Gong C; Wang L; Yang Z
Nanoscale; 2017 Sep; 9(37):14058-14064. PubMed ID: 28895610
[TBL] [Abstract][Full Text] [Related]
14. Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
Dong Y; Gao J; Pei M; Wang X; Zhang C; Du Y; Jiang Y
Int J Nanomedicine; 2020; 15():2685-2697. PubMed ID: 32368049
[TBL] [Abstract][Full Text] [Related]
15. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
[TBL] [Abstract][Full Text] [Related]
16. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
Wang K; Yang Y; Xue W; Liu Z
Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
[TBL] [Abstract][Full Text] [Related]
18. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
19. In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.
Han HD; Byeon Y; Jang JH; Jeon HN; Kim GH; Kim MG; Pack CG; Kang TH; Jung ID; Lim YT; Lee YJ; Lee JW; Shin BC; Ahn HJ; Sood AK; Park YM
Sci Rep; 2016 Dec; 6():38348. PubMed ID: 27910914
[TBL] [Abstract][Full Text] [Related]
20. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
